Physalin H, physalin B, and isophysalin B suppress the quorum-sensing function of Staphylococcus aureus by binding to

Junpei Yamaguchi1, Teruhisa Manome2,3, Yasumasa Hara2,4

  • 1Department of Infection Control Science, Graduate School of Pharmaceutical Sciences, Chiba University, Chiba, Japan.

PubMed

Insights

Physalins H, B, and isophysalin B from the Solanaceae family inhibit Staphylococcus aureus virulence by blocking the Agr quorum-sensing system. These compounds offer a promising anti-virulence strategy against methicillin-resistant S. aureus (MRSA) infections.

Area of Science:

  • Microbiology and Molecular Biology
  • Natural Product Chemistry
  • Pharmacology

Background:

  • Bacterial virulence, particularly in Staphylococcus aureus (including MRSA), is significantly influenced by toxins and virulence factors.
  • The accessory gene regulator (agr) locus controls these factors via a quorum-sensing (QS) system, making it a key target for anti-virulence strategies.

Purpose of the Study:

  • To identify phytochemicals that can inhibit the Agr quorum-sensing (Agr-QS) system function in Staphylococcus aureus.
  • To elucidate the precise molecular mechanism by which these identified phytochemicals exert their inhibitory effects.

Main Methods:

  • Screening of 577 compounds to identify Agr-QS modulators.
  • In vitro biological assays and protein-DNA binding experiments.
  • Molecular docking simulations and molecular dynamics (MD) simulations.

Main Results:

  • Physalin H, physalin B, and isophysalin B were identified as novel Agr-QS modulators.
  • These physalins suppress Agr-QS related gene expression by inhibiting AgrA binding to agr promoters, reducing hemolytic toxin activity.
  • Molecular simulations revealed specific binding interactions between physalins and the DNA-binding site of AgrA.

Conclusions:

  • Physalin H, physalin B, and isophysalin B effectively inhibit Staphylococcus aureus Agr-QS by targeting the AgrA protein-DNA interaction.
  • These physalins represent potential lead compounds for developing novel anti-virulence therapies against MRSA infections.
  • The study elucidates a specific mechanism involving physalin binding to AgrA's DNA-binding site, disrupting QS regulation.